Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

The document concludes that more research is needed to fully understand the causes of PCOS.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Birth control pills can help reduce mild to moderate acne in women.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.